Vanguard Group Inc 10x Genomics, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,972,930 shares of TXG stock, worth $157 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,972,930
Previous 10,189,257
7.69%
Holding current value
$157 Million
Previous $198 Million
25.02%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TXG
# of Institutions
290Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$154 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$92.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$91.5 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$91.2 Million1.67% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$91.2 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.36B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...